Acute coronary syndromes clinical care standard indicators: 6c-Proportion of patients with acute coronary syndrome (ACS) prescribed lipid-lowering therapy on separation from hospital, 2019-
Identifying and definitional attributes
|Metadata item type:||Indicator|
|Short name:||Indicator 6c-Proportion of patients with ACS prescribed lipid-lowering therapy on seperation from hospital|
|Registration status:||Australian Commission on Safety and Quality in Health Care, Standardisation pending 17/09/2019|
Proportion of patients with a final diagnosis of acute coronary syndrome (ACS) who are prescribed lipid-lowering therapy on separation from hospital.
|Indicator set:||Clinical care standard indicators: acute coronary syndromes Australian Commission on Safety and Quality in Health Care, Standardisation pending 17/09/2019|
Collection and usage attributes
Both the numerator and the denominator include patients with acute chest pain, or other symptoms suggestive of ACS.
The denominator excludes patients who died in hospital, statin-intolerant ACS patients, and other ACS patients for whom statins or other lipid-lowering therapies are contraindicated and for whom the contraindication is documented. Contraindications for statins may include advance care directives, being on a palliative care pathway, and clinical judgement, subject to discussion with patients, family and carers.
Presented as a percentage.
(Numerator ÷ denominator) x 100
Number of patients with a final diagnosis of ACS who are prescribed a statin or other lipid-lowering therapy on separation from hospital.
Number of patients with a final diagnosis of ACS who are separated from hospital.
|Unit of measure:||Episode|
Source and reference attributes
Australian Commission on Safety and Quality in Health Care
National Heart Foundation of Australia & Cardiac Society of Australia and New Zealand 2016 Executive Working Group 2016. Australian clinical guidelines for the management of acute coronary syndromes 2016. Heart, Lung, and Circulation 25: 895-951.